Johnson Midwest Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-14
Closed -$1K – 299
2021
Q3
$1K Buy
+14
New +$1.18K ﹤0.01% 286

Other funds holding ARKG

Johnson Midwest Financial's ARKG Position: Q4 2021 in Review

Johnson Midwest Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 14 shares — an estimated $1K sold.

Johnson Midwest Financial first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Johnson Midwest Financial reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Johnson Midwest Financial sold 14 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $1K.
  • Johnson Midwest Financial first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
  • Johnson Midwest Financial's ARK Genomic Revolution ETF position peaked at $1K in Q3 2021.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Johnson Midwest Financial's 13F filing for Q4 2021, filed 26 Jan 2022.